19F Thoracic Radiotherapy for Lung Cancer

Study summary

The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.

Ask AI to explain this study

Start here

Key things to know

Main goalDiagnostic

This describes the study’s primary purpose.

What is being studiedPerfluorinated Gas/Oxygen Mixture

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 16, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Early Phase 1

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Hal C Charles

Study sponsor

Study overview

What this study is about

Purpose: Diagnostic
Study type: Interventional
Phase: Early Phase 1
Sponsor: Hal C Charles
Interventions being studied: Drug: Perfluorinated Gas/Oxygen Mixture

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Subject has histologic or cytologic confirmation of lung cancer (NSCLC or Small cell) and has been recommended thoracic radiotherapy as part of standard of care management.
Ability to undergo MR imaging, tolerate breath hold procedures and follow direction during the imaging process
Karnofsky performance status ≥60, with expected survival of ≥6 months
At least 18 years of age
Patient is not pregnant
Patient can be reliably reached for post-MRI follow up AE check.
Patient able to sign a study specific informed consent form.

Reasons someone may not be able to joinExclusion criteria

Any condition including, metallic implants or cardiac pacemakers that makes the candidate ineligible for MR imaging. (MRI research screening form will be completed prior to each MRI scan).
Malignant pleural effusion or pericardial effusion

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Duke University Medical Center - Cancer CenterDurham, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 16, 2019. Always confirm current availability with the study team.

View original record ↗